Ovid Therapeutics Inc.
NASDAQ:OVID
0.7569 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -52.339 | -54.169 | 122.835 | -81.036 | -60.461 | -51.98 | -64.806 | -22.414 | -13.16 | -0.447 |
| Depreciation & Amortization
| 1.597 | 1.382 | 0.237 | 0.307 | 0.255 | 0.142 | 0.08 | 0.057 | 0.012 | 0.002 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0.005 | 0 | -3.641 | 0 | 0 |
| Stock Based Compensation
| 7.285 | 6.557 | 5.054 | 7.525 | 5.206 | 7.064 | 6.398 | 3.641 | 1.457 | 0.033 |
| Change In Working Capital
| 2.386 | -8.231 | -16.814 | 21.819 | 3.939 | -0.788 | 0.997 | 0.914 | 1.813 | 0.045 |
| Accounts Receivables
| 0 | 0 | 0.142 | 0.989 | -0.531 | 0 | 0.007 | 0.05 | -0.069 | 0 |
| Inventory
| 0 | 0 | -0.142 | -0.989 | 0.531 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 1.75 | -5.174 | 1.702 | 2.334 | -0.654 | 1.65 | 1.076 | 0.187 | 0.591 | 0 |
| Other Working Capital
| 0.636 | -3.057 | -18.517 | 19.485 | 4.593 | -2.438 | -0.079 | 0.728 | 1.221 | 0.045 |
| Other Non Cash Items
| -4.709 | -0.765 | 7.3 | -0.199 | -0.03 | -0.001 | 25.861 | 3.641 | 4.393 | 0.106 |
| Operating Cash Flow
| -45.781 | -55.227 | 118.612 | -51.584 | -51.091 | -45.558 | -31.47 | -17.802 | -5.485 | -0.261 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.04 | -1.419 | -0.189 | -0.391 | -0.244 | -0.352 | -0.047 | -0.189 | -0.056 | -0.002 |
| Acquisitions Net
| -10 | -2.5 | -1.632 | 0.263 | 0.187 | 0.318 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -112.443 | -172.964 | -1,631.992 | -9.961 | -34.797 | -50.012 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 120 | 90 | 1,637.392 | 45 | 5 | 45 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.097 | -1 | -5.4 | -0.263 | -0.187 | -0.318 | -0.008 | -0.159 | -0.024 | -0.004 |
| Investing Cash Flow
| -2.581 | -87.883 | -1.821 | 34.648 | -30.041 | -5.364 | -0.047 | -0.189 | -0.056 | -0.006 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.535 | 180.658 | 0.925 | 46.731 | 86.407 | 0.286 | 69.75 | 0 | 70.639 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 30.535 | 0.181 | 0.904 | 0.341 | 0.132 | 0.286 | -3.047 | -0.014 | 70.639 | 6.73 |
| Financing Cash Flow
| 30.535 | 0.181 | 0.904 | 47.072 | 86.539 | 0.286 | 66.703 | -0.014 | 70.639 | 6.73 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -17.826 | -142.93 | 117.694 | 30.137 | 5.408 | -50.636 | 35.186 | -18.005 | 65.097 | 6.463 |
| Cash At End Of Period
| 28.972 | 46.799 | 189.728 | 72.034 | 41.897 | 36.49 | 87.126 | 51.94 | 69.944 | 6.463 |